[Apparent protective effect of high density lipoprotein against coronary heart disease in the elderly]

Jian-zhai Li1, Man-li Chen, Shu Wang

  • 1Beijing Institute of Geriatrics, Beijing Hospital, Ministry of Health, Beijing 100730, China.

Zhonghua Yi Xue Za Zhi
|August 5, 2003
PubMed

Insights

Low high-density lipoprotein cholesterol (HDL-C) is a significant risk factor for acute myocardial infarction (AMI) and coronary heart disease (CHD) death in the elderly. Conversely, high HDL-C levels demonstrate a protective effect against coronary artery disease.

Area of Science:

  • Cardiovascular Medicine
  • Lipid Metabolism
  • Geriatric Cardiology

Context:

  • Investigating the role of high-density lipoprotein cholesterol (HDL-C) in cardiovascular health among the elderly Chinese population.
  • Understanding the association between varying HDL-C levels and the incidence of acute myocardial infarction (AMI) and coronary heart disease (CHD) mortality.

Purpose:

  • To evaluate the relationship between HDL-C levels and AMI events and CHD death.
  • To explore the protective effects of high HDL-C against CHD in elderly Chinese individuals.

Summary:

  • A prospective study followed 1211 elderly individuals for an average of 11.2 years, analyzing HDL-C levels in relation to AMI and CHD outcomes.
  • Results indicated that low HDL-C was a significant independent risk factor for AMI and CHD death, while high HDL-C showed a protective effect.
  • The study found that elevated total cholesterol (TC) levels could diminish the cardioprotective benefits of HDL-C.

Impact:

  • Highlights low HDL-C as a critical independent risk factor for AMI and CHD mortality in the elderly.
  • Establishes high HDL-C as a significant protective factor against coronary artery disease.
  • Suggests that managing total cholesterol is crucial for maximizing HDL-C's protective cardiovascular benefits.
Abstract

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution01:00

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are not...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...